Technology
LENDINGTREE REPORTS THIRD QUARTER 2026 RESULTS
Published
2 days agoon
By
Revenue Grew 12% YoY With Increases Across All Three Segments
Consolidated revenue of $343.6 millionGAAP net loss of $(72.4) million or $(5.15) per diluted share due to $98.8 million non-cash goodwill chargeVariable marketing margin of $94.9 millionAdjusted EBITDA of $39.6 million
CHARLOTTE, N.C., Nov. 3, 2026 /PRNewswire/ — LendingTree, Inc. (NASDAQ: TREE), operator of LendingTree.com, the nation’s leading online financial services marketplace, today announced results for the quarter ended September 30, 2026.
The company has posted a letter to shareholders on the company’s website at investors.lendingtree.com.
“We are pleased to report our tenth straight quarter of double-digit revenue growth, powered by continued strength in our Insurance segment along with healthy growth in Home driven by great home equity lending results,” said Scott Peyree, CEO. “This quarter we rolled-out AI features and distribution improvements to our shopping experience across multiple product lines. Specifically, we have implemented voice AI services to help consumers understand and choose the best offer before talking to a lender, AI overviews on offer pages that assist customers in selecting the best offer for their situation, and controlled distribution that helps a consumer shop in stages for a product to prevent multiple carriers or lenders from contacting the customer at once. Successful expansion of these types of features should ultimately improve consumer satisfaction and drive increased monetization of our traffic.”
Jason Bengel, CFO, commented, “The company is on track to grow revenue and AEBITDA this year by 17% and 14%, respectively, at the midpoint of our updated forecast. Our business benefits from the diversity of our product offering for consumers, providing one unified marketplace for all personal financial products. This diversification allows us to continue to execute on our growth plan successfully despite ongoing interest rate related headwinds impacting our Home segment. Our strong results continue to fortify our balance sheet, as we used excess cash to voluntarily repay $60 million of long-term debt during the quarter to improve free cashflow generation for shareholders going forward. Given the strength of our balance sheet and what we view as attractive valuation of our equity, we intend to repurchase shares during the the fourth quarter for the first time since 1Q22.”
Third Quarter 2026 Business Results
Insurance segment revenue of $234.9 million increased 15% over third quarter 2025 and translated into segment profit of $54.2 million, up 14% over the same period.Consumer segment revenue of $67.2 million increased 2% from third quarter 2025, while segment profit declined 16% over the same period.Home segment revenue of $41.5 million increased 9% over third quarter 2025 and produced segment profit of $12.4 million, an increase of 5% over the same period. Within Home, revenue from Home Equity of $34.0 million increased 20% over prior year.
LendingTree Summary Financial Metrics
(In millions, except per share amounts)
Three Months Ended
September 30,
Y/Y
Three Months Ended
June 30,
Q/Q
2026
2025
% Change
2026
% Change
Total revenue
$ 343.6
$ 307.8
12 %
$ 313.4
10 %
(Loss) income before income taxes
$ (78.4)
$ 11.6
(776) %
$ 14.1
(656) %
Income tax benefit (expense)
$ 6.0
$ (1.4)
(529) %
$ (4.5)
(233) %
Net (loss) income
$ (72.4)
$ 10.2
(810) %
$ 9.6
(854) %
Net (loss) income % of revenue
(21) %
3 %
3 %
Income per share
Basic
$ (5.15)
$ 0.75
$ 0.69
Diluted
$ (5.15)
$ 0.73
$ 0.68
Variable marketing margin
Total revenue
$ 343.6
$ 307.8
12 %
$ 313.4
10 %
Variable marketing expense (1) (2)
$ (248.7)
$ (214.6)
16 %
$ (226.1)
10 %
Variable marketing margin (2)
$ 94.9
$ 93.2
2 %
$ 87.3
9 %
Variable marketing margin % of revenue (2)
28 %
30 %
28 %
Adjusted EBITDA (2)
$ 39.6
$ 39.8
(1) %
$ 35.2
13 %
Adjusted EBITDA % of variable marketing margin (2)
42 %
43 %
40 %
(1)
Represents the portion of selling and marketing expense attributable to variable costs paid for advertising, direct marketing and related expenses. Excludes overhead, fixed costs and personnel-related expenses.
(2)
Variable marketing expense, variable marketing margin, variable marketing margin % of revenue, adjusted EBITDA, and adjusted EBITDA % of variable marketing margin are non-GAAP measures. Please see “LendingTree’s Reconciliation of Non-GAAP Measures to GAAP” and “LendingTree’s Principles of Financial Reporting” below for more information.
LendingTree Segment Results
(In millions)
Three Months Ended
September 30,
Y/Y
Three Months Ended June 30,
Q/Q
2026
2025
% Change
2026
% Change
Home (1)
Revenue
$ 41.5
$ 38.1
9 %
$ 43.9
(5) %
Segment profit
$ 12.4
$ 11.8
5 %
$ 11.3
10 %
Segment profit % of revenue
30 %
31 %
26 %
Consumer (2)
Revenue
$ 67.2
$ 66.2
2 %
$ 60.3
11 %
Segment profit
$ 29.6
$ 35.2
(16) %
$ 27.6
7 %
Segment profit % of revenue
44 %
53 %
46 %
Insurance (3)
Revenue
$ 234.9
$ 203.5
15 %
$ 209.3
12 %
Segment profit
$ 54.2
$ 47.6
14 %
$ 50.0
8 %
Segment profit % of revenue
23 %
23 %
24 %
Other (4)
Revenue
$ —
$ —
— %
$ —
— %
(Loss)
$ (0.1)
$ (0.1)
— %
$ (0.1)
— %
Total revenue
$ 343.6
$ 307.8
12 %
$ 313.4
10 %
Total segment profit
$ 96.1
$ 94.6
2 %
$ 88.8
8 %
Brand marketing expense (5)
$ (1.2)
$ (1.4)
(14) %
$ (1.5)
(20) %
Variable marketing margin
$ 94.9
$ 93.2
2 %
$ 87.3
9 %
Variable marketing margin % of revenue
28 %
30 %
28 %
(1)
The Home segment includes the following products: purchase mortgage, refinance mortgage, and home equity loans.
(2)
The Consumer segment includes the following products: credit cards, personal loans, small business loans, auto loans, deposit accounts and debt settlement.
(3)
The Insurance segment consists of insurance quote products.
(4)
The Other category primarily includes marketing revenue and related expenses not allocated to a specific segment.
(5)
Brand marketing expense represents the portion of selling and marketing expense attributable to variable costs paid for advertising, direct marketing and related expenses that are not assignable to the segments’ products. This measure excludes overhead, fixed costs and personnel-related expenses.
Financial Outlook*
Today we update our full-year 2026 outlook, and include the implied outlook for Q4:
Full-year 2026:*
Revenue of $1.30 to $1.31 billionVariable Marketing Margin of $370 – $375 millionAdjusted EBITDA of $151 – $153 million
Fourth-quarter 2026:*
Revenue: $315 – $325 millionVariable Marketing Margin: $88 – $93 millionAdjusted EBITDA: $34 – $36 million
*LendingTree is not able to provide a reconciliation of projected variable marketing margin or adjusted EBITDA to the most directly comparable expected GAAP results due to the unknown effect, timing and potential significance of the effects of legal matters and tax considerations. Expenses associated with legal matters and tax considerations have in the past, and may in the future, significantly affect GAAP results in a particular period.
Quarterly Conference Call
A conference call to discuss LendingTree’s third quarter 2026 financial results will be webcast live today, November 3, 2026 at 4:30 PM Eastern Time (ET). The live webcast is open to the public and will be available on LendingTree’s investor relations website at investors.lendingtree.com. Following completion of the call, a recorded replay of the webcast will be available on the website.
LENDINGTREE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
(in thousands, except per share amounts)
Revenue
$ 343,588
$ 307,792
$ 984,277
$ 797,636
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization shown
separately below) (1)
11,670
11,017
34,635
30,954
Selling and marketing expense (1)
260,508
225,051
735,529
574,555
General and administrative expense (1)
26,437
26,229
80,137
81,923
Product development (1)
10,243
11,297
31,742
34,674
Depreciation
4,147
3,995
12,609
12,533
Amortization of intangibles
1,258
1,288
3,834
3,902
Goodwill impairment
98,823
—
98,823
—
Restructuring and severance (1)
519
80
3,297
1,235
Litigation settlements and contingencies
260
69
1,036
15,279
Total costs and expenses
413,865
279,026
1,001,642
755,055
Operating (loss) income
(70,277)
28,766
(17,365)
42,581
Other income (expense), net:
Interest expense, net
(9,129)
(17,907)
(26,178)
(37,393)
Other income
1,009
732
2,210
2,368
(Loss) income before income taxes
(78,397)
11,591
(41,333)
7,556
Income tax benefit (expense)
6,033
(1,426)
(4,191)
(904)
Net (loss) income and comprehensive (loss) income
$ (72,364)
$ 10,165
$ (45,524)
$ 6,652
Weighted average shares outstanding:
Basic
14,040
13,623
13,944
13,538
Diluted
14,040
13,988
13,944
13,843
Net (loss) income per share:
Basic
$ (5.15)
$ 0.75
$ (3.26)
$ 0.49
Diluted
$ (5.15)
$ 0.73
$ (3.26)
$ 0.48
(1) Amounts include non-cash compensation, as follows:
Cost of revenue
$ 141
$ 73
$ 415
$ 101
Selling and marketing expense
1,012
652
2,538
1,987
General and administrative expense
3,098
3,647
9,101
15,510
Product development
645
630
2,106
2,238
Restructuring and severance
—
—
1,012
255
LENDINGTREE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
September 30,
2026
December 31,
2025
(in thousands, except par value
and share amounts)
ASSETS:
Cash and cash equivalents
$ 82,709
$ 81,073
Accounts receivable, net
165,004
110,582
Prepaid and other current assets
37,662
38,053
Total current assets
285,375
229,708
Property and equipment, net
29,194
32,834
Operating lease right-of-use assets
29,709
31,655
Goodwill
282,716
381,539
Intangible assets, net
34,258
38,092
Deferred income tax assets
120,939
124,867
Other non-current assets
22,050
16,997
Total assets
$ 804,241
$ 855,692
LIABILITIES:
Current portion of long-term debt
$ 3,936
$ 3,926
Accounts payable, trade
69,433
6,735
Accrued expenses and other current liabilities
108,801
126,803
Total current liabilities
182,170
137,464
Long-term debt
326,659
387,694
Operating lease liabilities
42,107
43,597
Other non-current liabilities
146
140
Total liabilities
551,082
568,895
Commitments and contingencies
SHAREHOLDERS’ EQUITY:
Preferred stock $0.01 par value; 5,000,000 shares authorized; none issued or outstanding
—
—
Common stock $0.01 par value; 50,000,000 shares authorized; 17,397,550 and 17,124,837 shares
issued, respectively, and 14,042,084 and 13,769,371 shares outstanding, respectively
174
171
Additional paid-in capital
1,292,786
1,280,903
Accumulated deficit
(773,623)
(728,099)
Treasury stock; 3,355,466 and 3,355,466 shares, respectively
(266,178)
(266,178)
Total shareholders’ equity
253,159
286,797
Total liabilities and shareholders’ equity
$ 804,241
$ 855,692
LENDINGTREE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended
September 30,
2026
2025
(in thousands)
Net cash provided by operating activities
76,448
56,575
Cash flows from investing activities:
Capital expenditures
(8,877)
(9,423)
Proceeds from sale of fixed assets
—
2,497
Other investing activities
52
—
Net cash used in investing activities
(8,825)
(6,926)
Cash flows from financing activities:
Proceeds from term loan
—
450,000
Repayment of term loan
(62,700)
(409,375)
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise
of stock options
(3,287)
(2,756)
Repayment and repurchase of 0.50% Convertible Senior Notes
—
(115,007)
Payment of revolver issuance costs
—
(1,432)
Payment of debt issuance costs
—
(5,095)
Payment of original issue discount
—
(4,000)
Net cash (used in) provided by financing activities
(65,987)
(87,665)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
1,636
(38,016)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
81,073
106,594
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
$ 82,709
$ 68,578
LENDINGTREE’S RECONCILIATION OF NON-GAAP MEASURES TO GAAP
Variable Marketing Expense
Below is a reconciliation of selling and marketing expense, the most directly comparable GAAP measure, to variable marketing expense. See “LendingTree’s Principles of Financial Reporting” for further discussion of the Company’s use of this non-GAAP measure.
Three Months Ended
September 30,
2026
June 30,
2026
September 30,
2025
(in thousands)
Selling and marketing expense
$ 260,508
$ 236,453
$ 225,051
Non-variable selling and marketing expense (1)
(11,868)
(10,370)
(10,483)
Variable marketing expense
$ 248,640
$ 226,083
$ 214,568
(1)
Represents the portion of selling and marketing expense not attributable to variable costs paid for advertising, direct marketing and related expenses. Includes overhead, fixed costs and personnel-related expenses.
LENDINGTREE’S RECONCILIATION OF NON-GAAP MEASURES TO GAAP
Variable Marketing Margin
Below is a reconciliation of net (loss) income, the most directly comparable GAAP measure, to variable marketing margin and net (loss) income % of revenue to variable marketing margin % of revenue. See “LendingTree’s Principles of Financial Reporting” for further discussion of the Company’s use of these non-GAAP measures.
Three Months Ended
September 30,
2026
June 30,
2026
September 30,
2025
(in thousands, except percentages)
Net (loss) income
$ (72,364)
$ 9,574
$ 10,165
Net (loss) income % of revenue
(21) %
3 %
3 %
Adjustments to reconcile to variable marketing margin:
Cost of revenue
11,670
11,269
11,017
Non-variable selling and marketing expense (1)
11,868
10,370
10,483
General and administrative expense
26,437
25,710
26,229
Product development
10,243
10,032
11,297
Depreciation
4,147
4,277
3,995
Amortization of intangibles
1,258
1,288
1,288
Goodwill impairment
98,823
—
—
Restructuring and severance
519
1,839
80
Litigation settlements and contingencies
260
756
69
Interest expense, net
9,129
8,483
17,907
Other income
(1,009)
(832)
(732)
Income tax (benefit) expense
(6,033)
4,573
1,426
Variable marketing margin
$ 94,948
$ 87,339
$ 93,224
Variable marketing margin % of revenue
28 %
28 %
30 %
(1)
Represents the portion of selling and marketing expense not attributable to variable costs paid for advertising, direct marketing and related expenses. Includes overhead, fixed costs and personnel-related expenses.
LENDINGTREE’S RECONCILIATION OF NON-GAAP MEASURES TO GAAP
Adjusted EBITDA
Below is a reconciliation of net (loss) income, the most directly comparable GAAP measure, to adjusted EBITDA and net (loss) income % of revenue to adjusted EBITDA % of revenue. See “LendingTree’s Principles of Financial Reporting” for further discussion of the Company’s use of these non-GAAP measures.
Three Months Ended
September 30,
2026
June 30,
2026
September 30,
2025
(in thousands, except percentages)
Net (loss) income
$ (72,364)
$ 9,574
$ 10,165
Net (loss) income % of revenue
(21) %
3 %
3 %
Adjustments to reconcile to adjusted EBITDA:
Amortization of intangibles
1,258
1,288
1,288
Depreciation
4,147
4,277
3,995
Restructuring and severance
519
1,839
80
Loss (gain) on impairments and disposal of assets
3
—
593
Goodwill impairment
98,823
—
—
Non-cash compensation
4,896
5,204
5,002
Litigation settlements and contingencies
260
756
69
Interest expense, net
9,129
8,483
17,907
Dividend income
(1,008)
(832)
(730)
Income tax (benefit) expense
(6,033)
4,573
1,426
Adjusted EBITDA
$ 39,630
$ 35,162
$ 39,795
Adjusted EBITDA % of revenue
12 %
11 %
13 %
LENDINGTREE’S PRINCIPLES OF FINANCIAL REPORTING
LendingTree reports the following non-GAAP measures as supplemental to GAAP:
Variable marketing expenseVariable marketing marginVariable marketing margin % of revenueEarnings Before Interest, Taxes, Depreciation and Amortization, as adjusted for certain items discussed below (“Adjusted EBITDA”)Adjusted EBITDA % of revenueAdjusted EBITDA % of variable marketing margin
Variable marketing expense, variable marketing margin and variable marketing margin % of revenue are related measures of the effectiveness of the Company’s marketing efforts. Variable marketing expense represents the portion of selling and marketing expense attributable to variable costs paid for advertising, direct marketing, and related expenses, and excludes overhead, fixed costs, and personnel-related expenses. Variable marketing margin is a measure of the efficiency of the Company’s operating model, measuring revenue after subtracting variable marketing expense. The Company’s operating model is highly sensitive to the amount and efficiency of variable marketing expenditures, and the Company’s proprietary systems are able to make rapidly changing decisions concerning the deployment of variable marketing expenditures (primarily but not exclusively online and mobile advertising placement) based on proprietary and sophisticated analytics.
Adjusted EBITDA, adjusted EBITDA % of revenue, and adjusted EBITDA % of variable marketing margin are primary metrics by which LendingTree evaluates the operating performance of its businesses, on which its marketing expenditures and internal budgets are based and, in the case of adjusted EBITDA, by which management and many employees are compensated in most years.
These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. LendingTree provides and encourages investors to examine the reconciling adjustments between the GAAP and non-GAAP measures set forth above.
Definition of LendingTree’s Non-GAAP Measures
Variable marketing margin is defined as revenue less variable marketing expense. Variable marketing expense is defined as the expense attributable to variable costs paid for advertising, direct marketing and related expenses, and excluding overhead, fixed costs and personnel-related expenses. The majority of these variable advertising costs are expressly intended to drive traffic to our websites and these variable advertising costs are included in selling and marketing expense on the Company’s consolidated statements of operations and consolidated income.
EBITDA is defined as net income excluding interest, income taxes, amortization of intangibles and depreciation.
Adjusted EBITDA is defined as EBITDA excluding (1) non-cash compensation expense, (2) non-cash impairment charges, (3) gain/loss on disposal of assets, (4) gain/loss on investments, (5) restructuring and severance expenses, (6) litigation settlements and contingencies, (7) acquisitions and dispositions income or expense (including with respect to changes in fair value of contingent consideration), (8) contributions to the LendingTree Foundation (9) dividend income, and (10) one-time items.
LendingTree endeavors to compensate for the limitations of these non-GAAP measures by also providing the comparable GAAP measures with equal or greater prominence and descriptions of the reconciling items, including quantifying such items, to derive the non-GAAP measures. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.
One-Time Items
Adjusted EBITDA is adjusted for one-time items, if applicable. Items are considered one-time in nature if they are non-recurring, infrequent or unusual, and have not occurred in the past two years or are not expected to recur in the next two years, in accordance with SEC rules. For the periods presented in this report, there are no adjustments for one-time items.
Non-Cash Expenses That Are Excluded From LendingTree’s Adjusted EBITDA
Non-cash compensation expense consists principally of expense associated with the grants of restricted stock, restricted stock units and stock options. These expenses are not paid in cash and LendingTree includes the related shares in its calculations of fully diluted shares outstanding. Upon settlement of restricted stock units, exercise of certain stock options or vesting of restricted stock awards, the awards may be settled on a net basis, with LendingTree remitting the required tax withholding amounts from its current funds. Cash expenditures for employer payroll taxes on non-cash compensation are included within adjusted EBITDA.
Amortization of intangibles are non-cash expenses relating primarily to acquisitions. At the time of an acquisition, the intangible assets of the acquired company, such as purchase agreements, technology and customer relationships, are valued and amortized over their estimated lives.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
The matters contained in the discussion above may be considered to be “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations or anticipations of LendingTree and members of our management team. Factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the following: adverse conditions in the primary and secondary mortgage markets and in the economy, particularly interest rates and inflation; default rates on loans, particularly unsecured loans; demand by investors for unsecured personal loans; the effect of such demand on interest rates for personal loans and consumer demand for personal loans; seasonality of results; potential liabilities to secondary market purchasers; changes in the Company’s relationships with network partners, including dependence on certain key network partners; breaches of network security or the misappropriation or misuse of personal consumer information; failure to provide competitive service; our ability to compete effectively and adapt to competitive pressures in each of our businesses, including from disintermediation as well as technological change, digital disruption and other types of innovation such as artificial intelligence; failure to maintain brand recognition; ability to attract and retain consumers in a cost-effective manner; the effects of potential acquisitions of other businesses, including the ability to integrate them successfully with LendingTree’s existing operations; accounting rules related to excess tax benefits or expenses on stock-based compensation that could materially affect earnings in future periods; ability to develop new products and services and enhance existing ones; effects of changing laws, rules or regulations on our business model; uncertainties relating to our illegal monopolization claims against Google, including the timing, amount and likelihood of recovery and the outcome of Google’s appeal of the ruling by the United States District Court for the District of Columbia in the government’s antitrust case against Google; allegations of failure to comply with existing or changing laws, rules or regulations, or to obtain and maintain required licenses; failure of network partners or other affiliated parties to comply with regulatory requirements; failure to maintain the integrity of systems and infrastructure; liabilities as a result of privacy regulations; failure to adequately protect intellectual property rights or allegations of infringement of intellectual property rights; and changes in management. These and additional factors to be considered are set forth under “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2025, in our Quarterly Report on Form 10-Q for the period ended June 30, 2026, and in our other filings with the Securities and Exchange Commission. LendingTree undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results or expectations.
About LendingTree, Inc.
LendingTree, Inc. is the parent of LendingTree, LLC and several companies owned by LendingTree, LLC (collectively, “LendingTree” or the “Company”).
LendingTree is one of the nation’s largest, most experienced online financial platforms, created to give consumers the power to win financially. LendingTree provides customers with access to the best offers on loans, credit cards, insurance and more through its network of approximately 770 financial partners. Since its founding, LendingTree has helped millions of customers obtain financing, save money, and improve their financial and credit health in their personal journeys. With a portfolio of innovative products and tools and personalized financial recommendations, LendingTree helps customers achieve everyday financial wins.
LendingTree, Inc. is headquartered in Charlotte, NC. For more information, please visit www.lendingtree.com.
Investor Relations Contact:
investors@lendingtree.com
Media Contact:
press@lendingtree.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lendingtree-reports-third-quarter-2026-results-302928407.html
SOURCE LendingTree, Inc.
You may like
―Third Quarter Marks Return to Year-on-Year Revenue Growth―
―Revenue from Federal Government Clients Increased 3.4% Sequentially―
―Margin Expansion Benefited from Efficient Contract Delivery and Favorable Contract Mix―
―Maintains 2026 Non-GAAP EPS Guidance Midpoint on Lower Revenue―
Third Quarter Highlights:
Revenue Increased 1% to $470 MillionNet Income Was $32 Million; GAAP EPS Was $1.76Non-GAAP EPS1 Increased 19% to $1.98EBITDA1 Was $53.6 Million; Adjusted EBITDA1 Was $54.2 Million, or 11.5% of Total RevenuesContract Awards Were $746 Million, 4.5% Ahead of Last Year and Representing a Quarterly Book-to-Bill Ratio of 1.59 and a TTM Book-to-Bill Ratio of 1.11
RESTON, Va., Nov. 5, 2026 /PRNewswire/ — ICF (NASDAQ: ICFI), a global consulting and technology services provider, reported results for the third quarter ended September 30, 2026.
Management Commentary
John Wasson, chair and chief executive officer, said, “Our third quarter performance demonstrated the return to year-on-year revenue growth that we anticipated would begin in the second half of this year and benefited from our diversified and integrated business model. Revenues from our federal government clients continued to show solid sequential growth in line with our expectations, and revenues from state and local and non-U.S. government clients increased 7.6% and 12.0% year-on-year, respectively.
“A key highlight of the third quarter was our strong margin performance, benefiting from efficient contract delivery and favorable contract mix. Our Adjusted EBITDA margin was 11.5%, expanding by 10 basis points year-on-year and representing a notable sequential increase. Fixed-price contracts accounted for 50.2% of our third quarter revenues, up from 48.7% in the similar period last year, and together with time & material contracts represented 94.3% of this quarter’s revenues. We are closely managing corporate costs, while continuing to invest in technology and professional staff to support client programs and capture new business opportunities.
“Third quarter revenues from commercial energy clients were considerably below our expectations due to a confluence of factors, most notably a sharp fall-off in contract add-on activity that historically has bolstered second half revenues in our utility programs category. There was a material increase in political and regulatory pressure on utilities in Q3 to develop affordable solutions for their customers, which has caused a slowdown and/or shift in incremental spending priorities for certain existing utility programs. Also, we experienced slower than expected ramp-ups on new contracts. As a result, ICF’s revenues from commercial energy clients are expected to increase at a low- to mid-single-digit rate for 2026. We continue to see commercial energy as a long-term growth driver for ICF. Our year-to-date contract awards have been strong, our win rates are increasing, and we are building a meaningful pipeline in areas where we see utility spending expanding, including audits/weatherization, demand response and virtual power plants.
“This also was a strong quarter for companywide contract awards, which increased 4.5% year-on-year to $746 million. Over 60% of our third quarter awards represented new business, a good indication of how well ICF’s capabilities and expertise are aligned with our clients’ priorities. Following this solid performance, our business development pipeline stood at $8.2 billion at the end of the third quarter and was well diversified across our client set.”
Third Quarter Business Highlights in Key Long-Term Growth Markets
Commercial Energy
ICF manages over 300 energy efficiency programs for 60 utilities in 28 states. Revenues from this part of the company’s commercial energy business were similar to last year’s levels due to the near-term challenges described above. We continue to see positive underlying momentum supported by year-to-date contract wins and client demand for our expertise as they address affordability issues together with operational imperatives around electrification and data center requirements. Energy advisory revenues increased 14.1% in the quarter and 10.5% year-to-date, with particular strength in our work on grid engineering and planning, transmission and interconnection, integrated power and gas planning, resource adequacy, technical due diligence, and storage. Additionally, our work with hyperscalers is expanding, and we are advising on a broader set of issues created by the scale of data center development, including energy efficiency, community impacts, power supply and reliability. As anticipated, other commercial energy comparisons declined year-on-year due to the wind-down of several wind energy projects through last year’s third quarter.
Commercial energy awards represented approximately 26% of year-to-date contract awards, and commercial energy opportunities represent more than $1.6 billion of our pipeline at the end of the third quarter.
ICF’s energy work includes programs for federal and state agencies that provide us with greater insight into the regulatory and stakeholder environment, which strengthens our ability to meet and often exceed the milestones of our commercial energy contracts.
Technology Modernization
ICF has built out its technology modernization capabilities over the last six years, which in the third quarter represented approximately 50% of our revenues from federal government clients. Over 80% of ICF’s technology modernization work is performed under outcome-based, fixed-price contracts, the preferred contract vehicles for government technology projects. Additionally, we continue to align our federal portfolio around administration priorities, with increased focus on expanding our footprint in the defense and national security arena, while building our brand in government-wide application modernization.
While primarily serving federal agency clients, our technology modernization capabilities are deployed across the company’s client categories. Technology modernization opportunities represented approximately $2.4 billion of our pipeline at the end of the third quarter.
State and Local Government/Disaster Recovery
The 7.6% revenue growth from state and local government clients in the third quarter illustrates ICF’s ability to leverage its deep domain expertise and robust technology capabilities across its client sets. Several of the projects driving growth in this client category include developing and managing energy efficiency programs in the Northeast and California, providing advanced technology solutions to several states and territories, and offering our rural health services.
During the quarter, ICF supported more than 50 active disaster recovery programs in more than 20 states and territories. While we view the disaster management market as a driver of long-term growth, funding delays and the slower pace of major events have constrained near-term activity in this arena. ICF continues to execute substantial rebuilding and mitigation projects utilizing our environmental and climate expertise, and we are helping our clients prepare to take on a larger role in rebuilding and resilience, having significantly increased our on-call contracts with state and local governments. State and local government opportunities represented approximately $1.1 billion of the total pipeline at the end of the third quarter.
Third Quarter 2026 Financial Results
Third quarter 2026 total revenue was $470.5 million, up 1.1% from the $465.4 million reported in the third quarter of 2025. Subcontractor and other direct costs were 23.6% of total revenues, compared to 24.2% in last year’s third quarter. Gross margin was 38.1%, 50 basis points above the prior year period. Operating income was $43.6 million, up 13.6% from $38.4 million, and operating margin expanded by 100 basis points to 9.3% from 8.3% in the prior year period. Net income totaled $31.7 million, or $1.76 per diluted share, up from net income of $23.8 million, or $1.28 per share reported in the third quarter of 2025, benefiting from a tax rate of 15.0% and a lower share count. In the prior year quarter, the company’s tax rate was 22.7%.
Non-GAAP EPS increased 18.6% to $1.98 per share, benefiting from the lower tax rate and share count mentioned above. EBITDA was $53.6 million, up from $52.8 million reported in the year-ago quarter. Adjusted EBITDA was $54.2 million, and Adjusted EBITDA margin on total revenues was 11.5%, compared to 11.4% in the third quarter of 2025.
Cash flows from operations were $35.2 million in this year’s third quarter. Excluding restricted cash mainly tied to energy efficiency programs, which fluctuates with the timing of incentive payments to utility customers, operating cash flow was $45.5 million, up from $17.3 million reported in the comparable prior year period. For the first nine months of 2026, cash flows from operations were $131.7 million. Excluding restricted cash, year-to-date operating cash flows were $88.7 million, up from $30.2 million in the first nine months of 2025, on a similarly adjusted basis.
Backlog and New Business
Total backlog was $3.5 billion at the end of the third quarter of 2026. Funded backlog was $1.8 billion, or approximately 52% of the total backlog. The total value of contracts awarded in the 2026 third quarter was $746 million for a quarterly book-to-bill ratio of 1.59 and trailing twelve-month contract awards totaled $2.0 billion for a book-to-bill ratio of 1.11.
Commercial Revenue Third Quarter 2026 Highlights
Commercial revenue was $158.8 million during the quarter, up 1.5% year-over-year.
Commercial revenue accounted for 33.8% of total revenue, similar to 33.6% of total revenue in the 2025 third quarter.Commercial energy revenues represented 88.6% of commercial revenue.
Key Commercial Contracts Awarded in the Third Quarter of 2026
Notable commercial contract awards won in the third quarter of 2026 included:
A contract modification with a Canadian electricity system organization to continue implementing a North American midstream lighting program to expand adoption of energy-efficient technologies by commercial and industrial customers.A new contract with a Mid-Atlantic U.S. electric utility to provide detailed engineering for transmission infrastructure.A new contract with a Mid-Atlantic U.S. utility to provide marketing and customer engagement services supporting its energy efficiency and energy management programs.A recompete contract with a Mid-Atlantic U.S. utility to provide ICF Sightline technology supporting its energy efficiency programs.A new contract with a Mid-Atlantic U.S. utility to provide marketing and customer engagement services supporting its customer programs.A new contract with a Northeastern U.S. utility to support its virtual power plant and battery energy storage program.
Government Revenue Third Quarter 2026 Highlights
Revenue from government clients was $311.7 million during the quarter.
U.S. federal government revenue was $191.3 million, 3.4% above the $185.1 million in the second quarter of 2026, and 3.5% below the $198.3 million reported in the year-ago third quarter. Year-on-year revenue comparisons were impacted by contract cancellations that occurred in 2025, and a slower pace of new RFPs. Federal government revenue accounted for 40.7% of total revenue, compared to 42.6% of total revenue in the third quarter of 2025.U.S. state and local government revenue was $87.9 million, 7.6% above the $81.7 million reported in the year-ago quarter. State and local government clients represented 18.7% of total revenue, compared to 17.6% in the third quarter of 2025.International government revenue was $32.5 million, up 12.0% from the $29.0 million reported in the year-ago quarter. International government revenue represented 6.9% of total revenue, compared to 6.2% in the third quarter of 2025.
Key Government Contracts Awarded in the Third Quarter of 2026
Notable government contract awards won in the third quarter of 2026 included:
A recompete contract with a value of $77.8 million with a federal health agency to provide technical assistance, training and capacity-building services to support the effective administration and delivery of state and territory childcare programs.Two new, multiyear work orders under the County of Los Angeles Energy Support Services Master Agreement with a combined ceiling value of $70.9 million to serve as one of three implementers supporting the Southern California Regional Energy Network’s public sector energy efficiency programs.Two new contracts with a combined value of $55.9 million with a federal national security agency to modernize technology systems supporting personnel security and vetting operations.Three contracts, one new and two recompetes, with a combined value of $36.4 million with a federal health agency to provide communications, marketing and strategic planning for nutrition and physical activity; prostate cancer awareness; and diabetes health education and support.A new contract with a value of $36.3 million with a federal agency to modernize a survey instrument by transitioning to digital collection, dashboards and AI-assisted tools while maintaining data security and statistical integrity.A recompete contract with a value of $22.6 million with a federal health agency to provide training and technical assistance to strengthen the delivery and effectiveness of early childhood programs serving children and families.A new contract with a value of $17.3 million with a federal public safety agency to modernize call center and case management technologies through platform-as-a-service solutions that enhance customer service and mission operations.A new contract with a value of $17.1 million with a federal law enforcement agency to modernize its human resources case management and hiring systems.A recompete contract with a ceiling value of $27.6 million with a federal environmental agency to provide laboratory, field sampling, data validation and quality assurance services.A recompete contract with a value of $15.4 million with a federal health and human services agency to provide compliance auditing, quality assurance and technical assistance services supporting federally funded care facilities.
Dividend Declaration
On November 5, 2026, ICF declared a quarterly cash dividend of $0.14 per share, payable on January 8, 2027, to shareholders of record on December 4, 2026.
Summary and Outlook
“ICF is on the path to second half year-on-year revenue growth, and we see positive momentum as we head into 2027. The adjusted EBITDA margin expansion we achieved in the third quarter was notable, our new contract awards were strong, and our business development pipeline is robust, all indications of the underlying strength of our business and effective cost management. Additionally, given ICF’s diversified portfolio, we see the midterm election results as a tailwind for our business.
“For full year 2026, we are expecting revenues to be similar to 2025 levels, with GAAP EPS of approximately $5.95, inclusive of $.11 of special charges. We are maintaining the midpoint of our Non-GAAP EPS guidance range of $7.10, representing 4.9% year-on-year growth and benefiting from improved margins, a lower interest rate and reduced share count. Operating cash flow is expected to range from $135 million to $150 million, excluding the impact of restricted cash.
“We continue to benefit from the energy of our people, who have shown tremendous dedication and commitment to our clients and embody the strong corporate culture that ICF is known for,” Mr. Wasson concluded.
1 Non-GAAP EPS, EBITDA and Adjusted EBITDA are non-GAAP measurements. A reconciliation of all non-GAAP measurements to the most applicable GAAP number is set forth below. Special charges are items that were included within our consolidated statements of comprehensive income but are not indicative of ongoing performance and have been presented net of applicable U.S. GAAP taxes. The presentation of non-GAAP measurements may not be comparable to other similarly titled measures used by other companies.
About ICF
ICF is a leading global solutions and technology provider. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.
Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, as amended. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to: the government contracting industry generally; our dependence on contracts with U.S. federal, state and local, and international government clients for the majority of our revenue; failure by Congress or other governmental bodies to approve budgets and appropriations in a timely fashion, reductions in government spending, and the impact of a lengthy federal government shutdown; the current Administration’s policy changes, executive orders, and failure to spend Congressionally mandated appropriations, including the resulting effect on government audits and contract terminations; changes in federal government budgeting and spending priorities; our ability to estimate and control costs under our fixed-price contracts; the realization of our backlog; the dependence of our commercial work on sectors of the global economy that are highly cyclical; and our ability to acquire and successfully integrate businesses. These and other factors that could cause our actual results to differ materially from those indicated in our forward-looking statements are described in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2025, and in our subsequent filings with the Securities and Exchange Commission. The forward-looking statements included herein are made only as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.
Note on Forward-Looking Non-GAAP Measures
The company does not reconcile its forward-looking non-GAAP financial measures to the corresponding U.S. GAAP measures, due to the variability and difficulty in making accurate forecasts and projections and because not all of the information necessary for a quantitative reconciliation of these forward-looking non-GAAP financial measures (such as the effect of share-based compensation or the impact of future extraordinary or non-recurring events like acquisitions) is available to the company without unreasonable effort. For the same reasons, the company is unable to estimate the probable significance of the unavailable information. The company provides forward-looking non-GAAP financial measures that it believes will be achievable, but it cannot accurately predict all of the components of the adjusted calculations, and the U.S. GAAP financial measures may be materially different than the non-GAAP financial measures.
Investor Contacts:
Lynn Morgen, ADVISIRY PARTNERS, lynn.morgen@advisiry.com +1.212.750.5800
David Gold, ADVISIRY PARTNERS, david.gold@advisiry.com +1.212.750.5800
Company Information Contact:
Lauren Dyke, ICF, lauren.dyke@ICF.com +1.571.373.5577
ICF International, Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
(Unaudited)
Three Months Ended
Nine Months Ended
September 30,
September 30,
(in thousands, except per share amounts)
2026
2025
2026
2025
Revenue
$ 470,497
$ 465,405
$ 1,382,492
$ 1,429,178
Direct Costs
291,310
290,545
859,803
891,512
Operating costs and expenses:
Indirect and selling expenses
125,632
122,261
367,787
377,169
Depreciation and amortization
9,908
14,168
36,512
43,665
Total operating costs and expenses
135,540
136,429
404,299
420,834
Operating income
43,647
38,431
118,390
116,832
Interest, net
(6,372)
(7,861)
(19,846)
(23,620)
Other income (expense)
58
176
(1,041)
(2,515)
Income before income taxes
37,333
30,746
97,503
90,697
Provision for income taxes
5,600
6,980
18,300
16,419
Net income
$ 31,733
$ 23,766
$ 79,203
$ 74,278
Earnings per Share:
Basic
$ 1.77
$ 1.29
$ 4.38
$ 4.03
Diluted
$ 1.76
$ 1.28
$ 4.36
$ 4.01
Weighted-average Shares:
Basic
17,939
18,432
18,063
18,447
Diluted
18,055
18,526
18,174
18,542
Cash dividends declared per common share
$ 0.14
$ 0.14
$ 0.42
$ 0.42
Other comprehensive income (loss), net of tax
3,299
(1,733)
3,908
1,712
Comprehensive income, net of tax
$ 35,032
$ 22,033
$ 83,111
$ 75,990
ICF International, Inc. and Subsidiaries
Reconciliation of Non-GAAP financial measures (2)
(Unaudited)
Three Months Ended
Nine Months Ended
September 30,
September 30,
(in thousands, except per share amounts)
2026
2025
2026
2025
Reconciliation of EBITDA and Adjusted EBITDA (3)
Net income
$ 31,733
$ 23,766
$ 79,203
$ 74,278
Interest, net
6,372
7,861
19,846
23,620
Provision for income taxes
5,600
6,980
18,300
16,419
Depreciation and amortization
9,908
14,168
36,512
43,665
EBITDA
53,613
52,775
153,861
157,982
Acquisition and divestiture-related expenses (4)
290
25
984
479
Severance and other costs related to staff realignment (5)
255
359
614
2,909
Charges and adjustments related to facility consolidations and office closures (6)
11
—
983
(138)
Total Adjustments
556
384
2,581
3,250
Adjusted EBITDA
$ 54,169
$ 53,159
$ 156,442
$ 161,232
Net Income Margin Percent on Revenue (7)
6.7 %
5.1 %
5.7 %
5.2 %
EBITDA Margin Percent on Revenue (8)
11.4 %
11.3 %
11.1 %
11.1 %
Adjusted EBITDA Margin Percent on Revenue (8)
11.5 %
11.4 %
11.3 %
11.3 %
Reconciliation of Non-GAAP Diluted EPS (3)
U.S. GAAP Diluted EPS
$ 1.76
$ 1.28
$ 4.36
$ 4.01
Acquisition and divestiture-related expenses
0.02
—
0.05
0.02
Severance and other costs related to staff realignment
0.01
0.02
0.02
0.16
Charges and adjustments related to facility consolidations and office closures
—
—
0.06
(0.01)
Amortization of intangible assets acquired in business combinations (9)
0.23
0.49
1.07
1.50
Income tax effects of the adjustments (10)
(0.04)
(0.12)
(0.22)
(0.38)
Non-GAAP Diluted EPS
$ 1.98
$ 1.67
$ 5.34
$ 5.30
(2) These tables provide reconciliations of Non-GAAP financial measures to the most applicable U.S. GAAP numbers. While we believe that these Non-GAAP financial measures may be useful in evaluating our financial information, they should be considered supplemental in nature and not as a substitute for financial information prepared in accordance with U.S. GAAP. Other companies may define similarly titled Non-GAAP measures differently and, accordingly, care should be exercised in understanding how we define these measures.
(3) Reconciliations of EBITDA, Adjusted EBITDA, and Non-GAAP Diluted EPS were calculated using numbers as reported in U.S. GAAP.
(4) These are primarily third-party costs related to potential and/or closed acquisitions and integration of closed acquisitions.
(5) These costs are due to involuntary employee termination benefits for (i) our officers and (ii) a group of employees who have been notified that they will be terminated as part of a business reorganization or exit.
(6) These charges and adjustments are related to previously exited leased facilities and the closure of certain international offices.
(7) Net Income Margin Percent on Revenue was calculated by dividing net income by revenue.
(8) EBITDA Margin Percent and Adjusted EBITDA Margin Percent on Revenue were calculated by dividing the Non-GAAP measure by the corresponding revenue.
(9) The amortization of intangible assets acquired from business combinations totaled $4.2 million and $9.2 million for the three months ended September 30, 2026 and 2025, respectively, and $19.4 million and $27.9 million for the nine months ended September 30, 2026 and 2025, respectively.
(10) Income tax effects were calculated using the effective tax rate, adjusted for certain discrete items, if any, of 15.0% and 22.7% for the three months ended September 30, 2026 and 2025, respectively, and 18.8% and 23.0% for the nine months ended September 30, 2026 and 2025, respectively.
ICF International, Inc. and Subsidiaries
Consolidated Balance Sheets
September 30, 2026
December 31, 2025
(in thousands, except share amounts)
(Unaudited)
ASSETS
Cash and cash equivalents
$ 5,138
$ 5,297
Restricted cash
89,955
47,984
Accounts receivable, net
229,810
237,996
Contract assets
213,384
186,684
Prepaid expenses and other current assets
28,273
18,390
Income tax receivable
20,656
18,087
Total Current Assets
587,216
514,438
Property and equipment, net
52,057
58,357
Goodwill
1,251,534
1,252,207
Other intangible assets, net
65,329
81,555
Operating lease – right-of-use assets
98,489
106,274
Other assets
47,257
37,340
Total Assets
$ 2,101,882
$ 2,050,171
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable
$ 90,814
$ 123,524
Contract liabilities
39,361
43,444
Lease liabilities – current
18,137
21,491
Accrued salaries and benefits
88,629
95,578
Accrued subcontractors and other direct costs
59,659
48,900
Accrued expenses and other current liabilities
121,879
71,340
Total Current Liabilities
418,479
404,277
Debt
372,122
401,355
Lease liabilities – non-current
136,097
148,493
Deferred income taxes
29,928
6,837
Other long-term liabilities
58,874
60,727
Total Liabilities
1,015,500
1,021,689
Commitments and Contingencies
Stockholders’ Equity:
Preferred stock, par value $.001; 5,000,000 shares authorized; none issued
—
—
Common stock, par value $.001; 70,000,000 shares authorized; 24,560,674 and 24,378,749 shares
issued at September 30, 2026 and December 31, 2025, respectively; 17,942,455 and 18,247,837
shares outstanding at September 30, 2026 and December 31, 2025, respectively
25
24
Additional paid-in capital
481,249
465,779
Retained earnings
1,027,716
956,077
Treasury stock, 6,618,219 and 6,130,912 shares at September 30, 2026 and December 31, 2025,
respectively
(413,088)
(379,970)
Accumulated other comprehensive loss
(9,520)
(13,428)
Total Stockholders’ Equity
1,086,382
1,028,482
Total Liabilities and Stockholders’ Equity
$ 2,101,882
$ 2,050,171
ICF International, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended
September 30,
(in thousands)
2026
2025
Cash Flows from Operating Activities
Net income
$ 79,203
$ 74,278
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for (recovery of) credit losses
458
(305)
Deferred income taxes and unrecognized income tax benefits
18,882
20,186
Non-cash equity compensation
13,314
12,915
Depreciation and amortization
36,512
43,665
Other operating adjustments, net
1,932
3,837
Changes in operating assets and liabilities, net of the effects of acquisitions:
Net contract assets and liabilities
(32,368)
(22,676)
Accounts receivable
7,334
26,829
Prepaid expenses and other current assets
(7,996)
(2,470)
Operating lease assets and liabilities, net
(6,197)
(6,774)
Accounts payable
(32,460)
(21,099)
Accrued salaries and benefits
(6,773)
(22,143)
Accrued subcontractors and other direct costs
11,405
(25)
Accrued expenses and other current liabilities
50,598
(9,804)
Income tax receivable and payable
(2,583)
(30,566)
Other liabilities
487
396
Net Cash Provided by Operating Activities
131,748
66,244
Cash Flows from Investing Activities
Payments for purchase of property and equipment and capitalized software
(14,080)
(14,745)
Other investing, net
(322)
403
Net Cash Used in Investing Activities
(14,402)
(14,342)
Cash Flows from Financing Activities
Advances from Credit Facility
1,191,161
1,048,671
Payments on Credit Facility
(1,220,728)
(1,011,838)
Other short-term borrowings, net
295
(5,822)
Dividends paid
(7,605)
(7,775)
Stock repurchases
(33,118)
(42,036)
Issuance of common stock under employee stock purchase plan
2,156
2,524
Payments of debt issuance costs
(4,442)
—
Repayment of finance lease obligations
(2,020)
(1,950)
Net Cash Used in Financing Activities
(74,301)
(18,226)
Effect of Exchange Rate Changes on Cash, Cash Equivalents, and Restricted Cash
(183)
1,433
Net Change in Cash, Cash Equivalents, and Restricted Cash
42,862
35,109
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period
56,324
18,817
Cash, Cash Equivalents, and Restricted Cash, End of Period
$ 99,186
$ 53,926
Supplemental Disclosure of Cash Flow Information
Cash paid during the period for:
Interest
$ 17,948
$ 20,045
Income tax payments, net of refunds
$ 2,575
$ 27,431
ICF International, Inc. and Subsidiaries
Supplemental Schedule (11)
Revenue by client market
Three Months Ended
Nine Months Ended
September 30,
September 30,
2026
2025
2026
2025
Energy, environment, infrastructure, and disaster recovery
54 %
53 %
53 %
51 %
Health and social programs
32 %
33 %
33 %
34 %
Security and other civilian & commercial
14 %
14 %
14 %
15 %
Total
100 %
100 %
100 %
100 %
Revenue by client type
Three Months Ended
Nine Months Ended
September 30,
September 30,
2026
2025
2026
2025
U.S. federal government
41 %
43 %
40 %
45 %
U.S. state and local government
18 %
17 %
18 %
17 %
International government
7 %
6 %
8 %
6 %
Total Government
66 %
66 %
66 %
68 %
Commercial
34 %
34 %
34 %
32 %
Total
100 %
100 %
100 %
100 %
Revenue by contract mix
Three Months Ended
Nine Months Ended
September 30,
September 30,
2026
2025
2026
2025
Time-and-materials
44 %
44 %
44 %
44 %
Fixed-price
50 %
49 %
50 %
49 %
Cost-based
6 %
7 %
6 %
7 %
Total
100 %
100 %
100 %
100 %
(11) As is shown in the supplemental schedule, we track revenue by key metrics that provide useful information about the nature of our operations. Client market provide insight into the breadth of our expertise. Client type is an indicator of the diversity of our client base. Revenue by contract mix provides insight in terms of the degree of performance risk that we have assumed.
View original content to download multimedia:https://www.prnewswire.com/news-releases/icf-reports-third-quarter-2026-results-302931259.html
SOURCE ICF
Technology
Globant to Announce Third Quarter 2026 Financial Results on November 19th
Published
59 minutes agoon
November 5, 2026By
LUXEMBOURG, Nov. 5, 2026 /PRNewswire/ — Globant (NYSE: GLOB), a digitally native company that helps organizations thrive in a digital and AI-powered future, today announced it will release results for the third quarter ended September 30th, 2026 on Thursday, November 19th, 2026 after the close of regular market hours.
Following the earnings release, Martin Migoya, Globant’s Chief Executive Officer & co-founder, Diego Tártara, Chief Technology Officer, Juan Urthiague, Chief Financial Officer, and Fernando Matzkin, Chief Operating Officer, will discuss the results in a video conference call and a live Q&A session beginning at 4:30 p.m. ET. A shareholder letter will also be available on the investor relations section of Globant’s website.
Video conference call access information is:
https://more.globant.com/F3Q26EarningsCall
About Globant (NYSE: GLOB)
Globant (NYSE: GLOB) is a global AI-native services company that helps organizations reinvent themselves and drive measurable business results by combining technology, creativity and innovation with AI at its core. Through Glob.AI, its AI-native technology services model and its signature AI Pods, agentic service units supervised by experts, the company delivers enterprise-grade technology services tied directly to core business metrics.
Present across 30+ countries, Globant operates a network of industry-specific AI Studios and partners with global brands including FIFA, Google, Riot Games, the LA Clippers and Santander. Recognized by IDC MarketScape as a Worldwide Leader in Experience Design Services (2025) and a Leader in AI Services (2023), Globant’s work is featured as business case studies at Harvard, MIT and Stanford. The company collaborates with leading technology platforms including Anthropic, NVIDIA, AWS and Unity.
For more information, please visit www.globant.com
Investor Relations Contact:
Arturo Langa, Globant
investors@globant.com
+1 (877) 215-5230
Media Contact:
Gregorio Lascano, Globant
pr@globant.com
+1 (877) 215-5230
View original content to download multimedia:https://www.prnewswire.com/news-releases/globant-to-announce-third-quarter-2026-financial-results-on-november-19th-302931085.html
SOURCE Globant
Technology
Cryoport Reports Third Quarter 2026 Financial Results
Published
59 minutes agoon
November 5, 2026By
Third quarter revenue grew 14% year-over-year to $50.2 millionCommercial Cell and Gene Therapy revenue increased 20% year-over-yearSupporting a record 788 global clinical trials and 23 commercially approved cell and gene therapies as of September 30, 2026Raises full-year 2026 revenue guidance to $197 million – $199 million
NASHVILLE, Tenn., Nov. 5, 2026 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its third quarter (Q3) and first nine months (9M) of 2026.
Jerrell Shelton, CEO of Cryoport, stated, “Cryoport delivered third quarter revenue of $50.2 million, reflecting continued momentum across our core cell and gene therapy (CGT) business. Revenue from commercial CGT clients increased 20% year over year, BioStorage/BioServices revenue expanded 25%, and total Life Sciences Services revenue grew 18%, underscoring the strength of our integrated platform and the growing demand for our solutions. These results reflect both the increasing number of patients worldwide receiving CGT treatments and the continued adoption of our end-to-end temperature-controlled supply chain solutions. We also achieved 8% year over year growth in Life Sciences Products revenue, supported by MVE Biological Solutions’ (MVE) position as the global market leader in cryogenic systems.
“During the quarter, we further strengthened our leadership position within the CGT ecosystem, ending the period supporting 23 commercial therapies and a record of 788 clinical trials worldwide. Our integrated platform, disciplined execution, and growing utilization of our Global Supply Chain Center Network continue to enhance scalability and operating leverage, advancing our progress toward sustained profitability. This momentum was reflected in our positive adjusted EBITDA of $1.1 million for the quarter, representing another important milestone in our pathway to profitability initiative.
“Our strong year-to-date performance, combined with expanding support of commercial therapies, deepening customer relationships, a robust clinical trial pipeline, and continued demand for MVE’s industry-leading products, gives us confidence in our outlook. As a result, we are increasing our full-year 2026 revenue guidance to a range of $197 million to $199 million,” concluded Mr. Shelton.
The following table presents Q3 2026 revenue compared with Q3 2025:
Cryoport, Inc. and Subsidiaries
Revenue
Three Months Ended
September 30,
(unaudited)
Nine Months Ended
September 30,
(unaudited)
(in thousands)
2026
2025
% Change
2026
2025
% Change
Life Sciences Services
$ 28,564
$ 24,258
18 %
$ 83,431
$ 71,492
17 %
BioLogistics Solutions
22,522
19,428
16 %
66,549
57,832
15 %
BioStorage/BioServices
6,042
4,830
25 %
16,882
13,660
24 %
Life Sciences Products
$ 21,656
$ 19,975
8 %
$ 63,558
$ 59,235
7 %
Total Revenue
$ 50,220
$ 44,233
14 %
$ 146,989
$ 130,727
12 %
BioLogistics Solutions revenue increased 16% year-over-year in Q3 2026, driven by continued commercial therapies development, and clinical trial progress within the CGT market. BioStorage/BioServices revenue grew 25% year-over-year, reflecting another strong quarter of demand for our expanded, integrated services offering, which provides seamless, secure handling of temperature-sensitive materials across our global network.
As of September 30, 2026, the number of commercial cell and gene therapies we support increased to 23 and our total global clinical trial count that we support rose to 788 clinical trials, a net increase of 43 clinical trials over September 30, 2025, with 99 of these clinical trials in Phase 3. The number of trials by phase and region are as follows:
Cryoport Supported Clinical Trials by Phase
Cryoport Supported Clinical Trials by Region
Clinical Trials
September 30,
Clinical Trials
September 30,
2024
2025
2026
2024
2025
2026
Phase 1
295
309
319
Americas
531
559
589
Phase 2
317
353
370
EMEA
112
137
143
Phase 3
79
83
99
APAC
48
49
56
Total
691
745
788
Total
691
745
788
In Q3 2026, Cryoport’s customer, Replimune, received accelerated U.S. Food and Drug Administration (FDA) approval for TUDRIQEV™ for the treatment of adults with unresectable advanced cutaneous melanoma, a skin cancer that has spread too widely or deeply to be safely or completely removed with surgery. Also, during the quarter Crispr Therapeutics and their partner Vertex Pharmaceuticals received FDA supplemental approval to expand the label of CASGEVY® for treatment of people 2 years of age and older with either Sickle Cell Disease (SCD) or Transfusion-dependent Beta Thalassemia (TDT). CASGEVY is the first approved genetic therapy indicated for children as young as 2 years for both SCD and TDT .
Two of Cryoport’s customers filed Biologics License Applications (BLA) with the FDA in the third quarter and we anticipate another five possible BLA or Marketing Authorization Applications (MAA) in 2026. Cryoport also anticipates two possible additional new therapy approvals (both of which have received Prescription Drug User Fee Act (PDUFA) dates from the FDA for Q4 2026), and one possible additional supplemental approval for geographic expansion from our customer base this year.
Operational Milestones
Cryoport Systems initiated BioLogistics services at its new state-of-the-art Global Supply Chain Center located in Santa Ana, California.Cryoport Systems’ Global Supply Chain Center in Paris, France, received ISO 9001 and ISO 21973 certifications. ISO 21973 certification is the first international standard developed specifically to address the transportation risks associated with human cells for therapeutic use.CRYOGENE secured new BioStorage and service contracts with customers including Houston Methodist Medical Center, Sonic Clinical Trials, and XenoSTART.
Financial Highlights
On June 11, 2025, the Company completed the divestiture of its CRYOPDP specialty courier business to DHL Group. The results of CRYOPDP, a former business within Cryoport’s Life Sciences Services segment, are presented as discontinued operations for all periods and are excluded from the non-GAAP financial measures in this release.
Revenue
Total revenue for Q3 2026 was $50.2 million, compared to $44.2 million for Q3 2025, a year-over-year increase of 14%, or $6.0 million. Life Sciences Services revenue for Q3 2026 (representing 57% of our total revenue) was $28.6 million, compared to $24.3 million for Q3 2025, up 18% year-over-year, including BioStorage/BioServices revenue of $6.0 million, up 25% year-over-year. Life Sciences Products revenue for Q3 2026 (representing 43% of our total revenue) was $21.7 million, compared to $20.0 million for Q3 2025.Total revenue for 9M 2026 was $147.0 million, compared to $130.7 million for 9M 2025. Life Sciences Services revenue for 9M 2026 was $83.4 million, compared to $71.5 million for 9M 2025, including BioStorage/BioServices revenue of $16.9 million, compared to $13.7 million for 9M 2025. Life Sciences Products revenue for 9M 2026 was $63.6 million, compared to $59.2 million for 9M 2025.
Gross Margin
Total gross margin was 47.5% for Q3 2026, compared to 48.2% for Q3 2025. Gross margin for Life Sciences Services was 50.4% for Q3 2026, compared to 49.7% for Q3 2025. Gross margin for Life Sciences Products was 43.6% for Q3 2026, compared to 46.4% for Q3 2025.Total gross margin was 46.7% for 9M 2026, compared to 46.9% for 9M 2025. Gross margin for Life Sciences Services was 49.7% for 9M 2026, compared to 48.8% for 9M 2025. Gross margin for Life Sciences Products was 42.6% for 9M 2026, compared to 44.6% for 9M 2025.
Operating Costs and Expenses
Operating costs and expenses were $32.6 million for Q3 2026, compared to $31.3 million for Q3 2025. Operating costs and expenses were $97.0 million for 9M 2026, compared to $88.1 million for 9M 2025.
Loss from Continuing Operations
Loss from continuing operations was $10.9 million for Q3 2026, compared to a loss of $6.7 million for Q3 2025. Loss from continuing operations was $28.5 million for 9M 2026, compared to a loss of $25.4 million for 9M 2025.
Net Income (Loss) – including Discontinued Operations
Net loss was $10.9 million for Q3 2026, compared to net loss of $6.9 million for Q3 2025. Net loss for 9M 2026 was $29.7 million, compared to net income of $89.9 million for 9M 2025. Net income for 9M 2025 was primarily driven by the sale of our CRYOPDP specialty courier business during Q2 2025, which contributed $115.4 million, net of taxes, to income from discontinued operations.Net loss attributable to common stockholders for Q3 2026 was $12.9 million, or $0.25 per share. Net loss attributable to common stockholders for 9M 2026 was $35.7 million, or $0.71 per share. This compares to net loss attributable to common stockholders of $8.9 million, or $0.18 per share, and net income attributable to common stockholders of $83.9 million, or $1.68 per share, for Q3 2025 and 9M 2025, respectively.
Adjusted EBITDA from Continuing Operations
Adjusted EBITDA from continuing operations was $1.1 million for Q3 2026, compared to a negative $0.6 million for Q3 2025. Adjusted EBITDA from continuing operations for 9M 2026 was $0.9 million, compared to a negative $4.4 million for 9M 2025.
Cash, Cash equivalents, and Short-Term Investments
Cryoport held $393.1 million in cash, cash equivalents, and short-term investments as of September 30, 2026.
Revenue Guidance for Full-Year 2026
The Company is providing updated full-year 2026 revenue guidance in the range of $197 million to $199 million. The Company’s 2026 revenue guidance is dependent on its current business and expectations, which may be impacted by, among other things, factors that are outside of our control, such as national economic factors, the global macroeconomic and geopolitical environment, supply chain constraints, inflationary pressures, tariffs and other trade restrictions and/or the effects of foreign currency fluctuations, as well as the other factors described in the Company’s filings with the Securities and Exchange Commission (“SEC”), including in the “Risk Factors” section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC.
Note: All reconciliations of GAAP to adjusted (non-GAAP) figures above are detailed in the reconciliation tables included later in the press release.
Additional Information
Further information on Cryoport’s financial results is included in the attached condensed consolidated balance sheets and statements of operations, and additional explanations of Cryoport’s financial performance are provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, which is expected to be filed with the Securities and Exchange Commission (“SEC”) on November 5, 2026. Additionally, the full report will be available in the SEC Filings section of the Investor Relations section of Cryoport’s website at www.cryoportinc.com.
Earnings Conference Call Information
IMPORTANT INFORMATION: In addition to the earnings release, a document titled “Cryoport Third Quarter 2026 in Review,” providing a review of Cryoport’s business update, will be issued at 4:05 p.m. ET on Thursday, November 5, 2026. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.
Cryoport management will host a conference call at 5:00 p.m. ET on November 5, 2026. The conference call will be in the format of a questions and answers session and will address any queries investors have regarding the Company’s reported results. A slide deck will accompany the call.
Conference Call Information
Date:
Thursday, November 5, 2026
Time:
5:00 p.m. ET
Dial-in numbers:
1-800-717-1738 (U.S.), 1-646-307-1865 (International)
Confirmation code:
Request the “Cryoport Call” or Conference ID: 1107312
Live webcast:
‘Investor Relations’ section at www.cryoportinc.com or click here.
Please allow 10 minutes prior to the call to visit this site to download and install
any necessary audio software.
The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company’s website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until November 12, 2026. To access the replay, dial 1-844-512-2921 (United States) or 1-412-317-6671 (International) and enter replay entry code: 1107312#.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the life sciences. Our integrated supply chain platform includes the Cryoportal® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized BioLogistics, BioStorage, BioServices, cryopreservation services, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are “Enabling the Future of Medicine™.”
Headquartered in Nashville, Tennessee, our company maintains a strong global presence with operations across the Americas, EMEA, and APAC.
For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at https://x.com/cryoport for live updates.
Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding the Company’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to the Company’s industry, business, long-term growth prospects, plans, strategies, acquisitions, future financial results and financial condition, such as the Company’s outlook and guidance for full-year 2026 revenue and the related assumptions and factors expected to drive revenue, projected growth trends in the markets in which the Company operates, the Company’s plans and expectations regarding the launch of new products and services, such as the expected timing and benefits of such products and services launches, the Company’s expectations about future benefits of its acquisitions, and anticipated regulatory filings, approvals, label/geographic expansions or moves to earlier lines of treatment approved with respect to the products of the Company’s clients. Forward-looking statements also include those related to the Company’s plans regarding its Global Supply Chain Centers, including expected timing of future openings, the Company’s anticipation that it will benefit from its operating leverage, the Company’s belief that it is well positioned to further expand margins, enhance operating efficiency and deliver sustainable, profitable long-term growth for its shareholders, and the Company’s expectation that upcoming growth catalysts in its business segments will drive the Company to new heights in market position, growth, and productivity. It is important to note that the Company’s actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effects of changing economic and geopolitical conditions, such as those resulting from the war with Iran, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in the Company’s cash flow, market acceptance risks, the effects of tariffs and other trade restrictions, and technical development risks. The Company’s business could be affected by other factors discussed in the Company’s SEC reports, including in the “Risk Factors” section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and the Company cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, the Company disclaims any obligation and does not undertake to update or revise any forward-looking statements in this press release.
Cryoport, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
Three Months Ended
September 30,
(unaudited)
Nine Months Ended
September 30,
(unaudited)
(in thousands, except share and per share data)
2026
2025
2026
2025
Revenue
Life Sciences Services revenue
$ 28,564
$ 24,258
$ 83,431
$ 71,492
Life Sciences Products revenue
21,656
19,975
63,558
59,235
Total revenue
50,220
44,233
146,989
130,727
Cost of revenue:
Cost of services revenue
14,181
12,201
41,936
36,570
Cost of products revenue
12,205
10,707
36,482
32,814
Total cost of revenue
26,386
22,908
78,418
69,384
Gross margin
23,834
21,325
68,571
61,343
Operating costs and expenses:
Selling, general and administrative
27,904
26,734
83,535
75,543
Engineering and development
4,734
4,523
13,493
12,575
Total operating costs and expenses
32,638
31,257
97,028
88,118
Loss from operations
(8,804)
(9,932)
(28,457)
(26,775)
Other income (expense):
Investment income
3,027
3,402
9,249
6,441
Interest expense
(517)
(526)
(1,467)
(1,727)
Other income (expense), net
(4,364)
525
(7,057)
(2,714)
Loss before provision for income taxes
(10,658)
(6,531)
(27,732)
(24,775)
Provision for income taxes
(194)
(165)
(807)
(673)
Loss from continuing operations
$ (10,852)
$ (6,696)
$ (28,539)
$ (25,448)
Income (loss) from discontinued operations, net
–
(247)
(1,112)
115,393
Net income (loss)
$ (10,852)
$ (6,943)
$ (29,651)
$ 89,945
Paid-in-kind dividend on Series C convertible preferred stock
(2,000)
(2,000)
(6,000)
(6,000)
Net income (loss) attributable to common stockholders
$ (12,852)
$ (8,943)
$ (35,651)
$ 83,945
Net income (loss) per share attributable to common stockholders – basic and diluted
$ (0.25)
$ (0.18)
$ (0.71)
$ 1.68
Weighted average common shares issued and outstanding – basic and diluted
50,653,987
50,125,268
50,335,554
50,110,450
Cryoport, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
September 30,
December 31,
2026
2025
(in thousands)
(unaudited)
Current assets
Cash and cash equivalents
$ 279,179
$ 250,494
Short-term investments
113,897
160,714
Accounts receivable, net
36,004
33,359
Inventories
22,438
23,188
Prepaid expenses and other current assets
5,186
8,419
Total current assets
456,704
476,174
Property and equipment, net
96,367
85,448
Operating lease right-of-use assets
39,473
39,720
Intangible assets, net
133,277
138,082
Goodwill
22,030
22,400
Deposits
1,998
2,092
Deferred tax assets
1,096
1,073
Total assets
$ 750,945
$ 764,989
Current liabilities
Accounts payable and other accrued expenses
$ 16,347
$ 15,283
Accrued compensation and related expenses
14,731
12,980
Deferred revenue
1,455
943
Current portion of operating lease liabilities
4,378
4,133
Current portion of finance lease liabilities
448
422
Current portion of convertible senior notes, net
185,986
185,094
Current portion of notes payable
159
163
Current portion of contingent consideration
674
–
Total current liabilities
224,178
219,018
Notes payable, net
947
1,087
Operating lease liabilities, net
38,905
39,078
Finance lease liabilities, net
688
741
Deferred tax liabilities
1,748
1,354
Other long-term liabilities
965
444
Contingent consideration
–
629
Total liabilities
267,431
262,351
Total stockholders’ equity
483,514
502,638
Total liabilities and stockholders’ equity
$ 750,945
$ 764,989
Note Regarding Use of Non-GAAP Financial Measures
To supplement our financial statements, which are presented on the basis of U.S. generally accepted accounting principles (GAAP), the following non-GAAP measure of financial performance as defined in Regulation G of the Securities Exchange Act of 1934 is included in this release: adjusted EBITDA from continuing operations. Non-GAAP financial measures are not calculated in accordance with GAAP, are not based on any comprehensive set of accounting rules or principles and may be different from non-GAAP financial measures presented by other companies. Non-GAAP financial measures, including adjusted EBITDA from continuing operations, should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.
Adjusted EBITDA from continuing operations is defined as loss from continuing operations adjusted for net interest expense, income taxes, depreciation and amortization expense, stock-based compensation expense, acquisition and integration costs, cost reduction initiatives, investment income, unrealized (gain)/loss on investments, foreign currency loss, changes in fair value of contingent consideration and charges or gains resulting from non-recurring events, as applicable.
Management believes that adjusted EBITDA from continuing operations provides a useful measure of Cryoport’s operating results, a meaningful comparison with historical results and with the results of other companies, and insight into Cryoport’s ongoing operating performance. Further, management and the Company’s board of directors utilize adjusted EBITDA from continuing operations to gain a better understanding of Cryoport’s comparative operating performance from period to period and as a basis for planning and forecasting future periods. Adjusted EBITDA from continuing operations is also a significant performance measure used by Cryoport in connection with its incentive compensation programs. Management believes adjusted EBITDA from continuing operations, when read in conjunction with Cryoport’s GAAP financials, is useful to investors because it provides a basis for meaningful period-to-period comparisons of Cryoport’s ongoing operating results, including results of operations, against investor and analyst financial models, helps identify trends in Cryoport’s underlying business and in performing related trend analyses, and it provides a better understanding of how management plans and measures Cryoport’s underlying business.
Cryoport, Inc. and Subsidiaries
Reconciliation of GAAP loss from continuing operations to adjusted EBITDA
(unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
(in thousands)
GAAP loss from continuing operations
$ (10,852)
$ (6,696)
$ (28,539)
$ (25,448)
Non-GAAP adjustments to loss:
Depreciation and amortization expense
6,467
6,415
19,458
18,798
Acquisition and integration costs
25
38
25
69
Cost reduction initiatives
857
160
997
642
Investment income
(3,027)
(3,402)
(9,249)
(6,441)
Unrealized (gain) loss on investments
4,171
(655)
6,064
620
Foreign currency loss
380
274
1,485
2,521
Interest expense, net
517
526
1,467
1,727
Stock-based compensation expense
2,346
2,526
7,143
7,635
Change in fair value of contingent consideration
25
—
67
(5,178)
Income taxes
194
165
807
673
Other adjustments
—
—
1,142
—
Adjusted EBITDA from continuing operations
$ 1,103
$ (649)
$ 867
$ (4,382)
View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-reports-third-quarter-2026-financial-results-302931284.html
SOURCE Cryoport, Inc.
ICF Reports Third Quarter 2026 Results
Globant to Announce Third Quarter 2026 Financial Results on November 19th
Cryoport Reports Third Quarter 2026 Financial Results
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoFrom IFA Berlin to CES 2027: OlloBot Continues Its Journey in Emotional Companionship
-
Technology5 days agoContext Labs AI Distillery™ Lets Enterprises Run Sovereign AI on Data They Own
-
Technology5 days agoA new way to explore Japan with AI: Naviu AR Travel Companion for Japan Launches November 1 2026
-
Coin Market4 days agoBinance net outflows surge to $5.8B as withdrawals resume after record hack
-
Coin Market4 days agoTHORChain halts swaps after block reorg bug, slowing Binance hackers
-
Technology4 days agoRD Technologies Upgrades Its Cross-Border Payments and Digital Finance Ecosystem
-
Technology4 days agoThunes and UnionPay International Transform Payments to China’s Mainland, Launching High-Capacity Instant Payouts
-
Technology3 days agoAGIBOT Unveils GO-3 Preview, Takes Top Spot on Three Embodied AI Benchmarks